WallStSmart

Advanced Micro Devices Inc (AMD)vsCommScope Holding Company, Inc. (VISN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Advanced Micro Devices Inc generates 1758% more annual revenue ($37.45B vs $2.02B). VISN leads profitability with a 347.7% profit margin vs 13.4%. AMD appears more attractively valued with a PEG of 1.28. VISN earns a higher WallStSmart Score of 74/100 (B).

AMD

Buy

61

out of 100

Grade: C+

Growth: 9.3Profit: 5.5Value: 4.3Quality: 9.0
Piotroski: 6/9Altman Z: 3.74

VISN

Strong Buy

74

out of 100

Grade: B

Growth: 6.7Profit: 6.5Value: 5.0Quality: 7.0
Piotroski: 5/9Altman Z: 0.34

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMD6 strengths · Avg: 9.7/10
Market CapQuality
$887.75B10/10

Mega-cap, among the largest globally

Revenue GrowthGrowth
37.8%10/10

Revenue surging 37.8% year-over-year

EPS GrowthGrowth
91.2%10/10

Earnings expanding 91.2% YoY

Debt/EquityHealth
0.0610/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
3.7410/10

Safe zone — low bankruptcy risk

Free Cash FlowQuality
$2.57B8/10

Generating 2.6B in free cash flow

VISN6 strengths · Avg: 9.3/10
Price/BookValuation
0.6x10/10

Reasonable price relative to book value

Profit MarginProfitability
347.7%10/10

Keeps 348 of every $100 in revenue as profit

EPS GrowthGrowth
704.0%10/10

Earnings expanding 704.0% YoY

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

P/E RatioValuation
17.4x8/10

Attractively priced relative to earnings

Revenue GrowthGrowth
21.6%8/10

Revenue surging 21.6% year-over-year

Areas to Watch

AMD3 concerns · Avg: 3.0/10
Price/BookValuation
12.3x4/10

Trading at 12.3x book value

Return on EquityProfitability
7.8%3/10

ROE of 7.8% — below average capital efficiency

P/E RatioValuation
181.7x2/10

Premium valuation, high expectations priced in

VISN3 concerns · Avg: 2.0/10
PEG RatioValuation
2.942/10

Expensive relative to growth rate

Free Cash FlowQuality
$-228.80M2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.342/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : AMD

The strongest argument for AMD centers on Market Cap, Revenue Growth, EPS Growth. Revenue growth of 37.8% demonstrates continued momentum. PEG of 1.28 suggests the stock is reasonably priced for its growth.

Bull Case : VISN

The strongest argument for VISN centers on Price/Book, Profit Margin, EPS Growth. Profitability is solid with margins at 347.7% and operating margin at 7.1%. Revenue growth of 21.6% demonstrates continued momentum.

Bear Case : AMD

The primary concerns for AMD are Price/Book, Return on Equity, P/E Ratio. A P/E of 181.7x leaves little room for execution misses.

Bear Case : VISN

The primary concerns for VISN are PEG Ratio, Free Cash Flow, Altman Z-Score.

Key Dynamics to Monitor

AMD carries more volatility with a beta of 2.47 — expect wider price swings.

AMD is growing revenue faster at 37.8% — sustainability is the question.

AMD generates stronger free cash flow (2.6B), providing more financial flexibility.

Monitor SEMICONDUCTORS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

VISN scores higher overall (74/100 vs 61/100), backed by strong 347.7% margins and 21.6% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Advanced Micro Devices Inc

TECHNOLOGY · SEMICONDUCTORS · USA

Advanced Micro Devices, Inc. (AMD) is an American multinational semiconductor company based in Santa Clara, California, that develops computer processors and related technologies for business and consumer markets. AMD's main products include microprocessors, motherboard chipsets, embedded processors and graphics processors for servers, workstations, personal computers and embedded system applications.

Visit Website →

CommScope Holding Company, Inc.

TECHNOLOGY · COMMUNICATION EQUIPMENT · USA

Gyroscope Therapeutics Holdings plc, a clinical-stage gene therapy company, develops gene therapy products to treat patients with eye diseases. The company is headquartered in Stevenage, the United Kingdom.

Want to dig deeper into these stocks?